Lingumelt Akut

Loperamide Hydrochloride, the active ingredient in Lingumelt Akut, is an antidiarrheal presented as an oral tablet for oral use. It reduces the frequency of watery stools and is used to manage acute nonspecific diarrhea in adults and children. GNH USA supplies Lingumelt Akut as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lingumelt Akut contains loperamide, an antidiarrheal that acts on the gastrointestinal tract to control excess stool output. - Acute nonspecific diarrhea: decreases stool frequency and improves consistency. - Travelers' diarrhea: provides rapid symptomatic relief for short‑term diarrheal episodes during travel. - Chronic idiopathic diarrhea (e.g., IBS‑D): helps control loose stools when other therapies are insufficient.

Loperamide is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Abdominal cramps or discomfort - Constipation - Nausea - Dry mouth - Dizziness - Headache

Serious or Rare Side Effects: - Severe constipation or paralytic ileus - Toxic megacolon, especially in infectious diarrhea - Allergic reactions such as rash, pruritus, or angioedema - Cardiac arrhythmias, including QT prolongation, particularly when combined with other QT‑prolonging agents

When using Lingumelt Akut, consider the following safety measures. - Hepatic impairment: adjust dose or monitor closely. - Children under 2 years: avoid use unless specifically directed by a physician. - Infectious diarrhea: do not use if the cause is bacterial enterocolitis without physician guidance. - Concomitant antidiarrheals: avoid combining with other agents that slow gut motility. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Loperamide may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of toxicity. - Other opioid analgesics: additive risk of central nervous system depression. - QT‑prolonging agents (e.g., macrolide antibiotics, certain antipsychotics): heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Anticholinergic medications: may exacerbate constipation. - Diuretics: increased potential for dehydration and electrolyte imbalance. - Antihistamines: may enhance sedation or dizziness.